| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.7113 | 
      | Human Intestinal Absorption | HIA- | 0.8442 | 
      | Caco-2 Permeability | Caco2- | 0.8957 | 
      | P-glycoprotein Substrate | Non-substrate | 0.5759 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7598 | 
                                                     | Non-inhibitor | 0.8400 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7480 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7796 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8470 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8591 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6168 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9418 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9095 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9278 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8373 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9410 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8369 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9653 | 
                                                                    | Non-inhibitor | 0.7675 | 
      | AMES Toxicity | Non AMES toxic | 0.9202 | 
      | Carcinogens | Non-carcinogens | 0.9565 | 
      | Fish Toxicity | Low FHMT | 0.5550 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7324 | 
      | Honey Bee Toxicity | High HBT | 0.7212 | 
      | Biodegradation | Not ready biodegradable | 0.9116 | 
      | Acute Oral Toxicity | IV | 0.5888 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6497 |